SEC Form 4 · accession 0000899243-15-010241
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey S Farrow
Officer — Chief Financial Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (ISO) | $56.31 | Dec 17, 2015 | D | 7,100 | D | Jul 8, 2016 | Jul 7, 2025 | Common Stock | 7,100 | 0 | D |
| Employee Stock Option (NQ) | $56.31 | Dec 17, 2015 | D | 77,900 | D | Jul 8, 2016 | Jul 7, 2025 | Common Stock | 77,900 | 0 | D |